• Deutsch (DE-CH-AT)
  • English (United Kingdom)

NOTICE

with regard to the manufacturing license:
TICEBA possesses the required authorization by the competent authority for the manufacturing of tissue as source material of human origin for the manufacturing of pharmaceuticals in accordance with § 20 b and § 20 c of the German Medicines Act: Authorization for the treatment or processing, preservation, storage of tissue or tissue preparations.

Links and online resources


• BIOPRO - Life Science Portal
• Children's Hospital, Professor Markus H. Frank, M.D.
• Center for Human Genetic Research, Dr. Natasha Frank, M.D.
• Dana-Farber / Harvard Cancer Center, Professor Markus H. Frank, M.D.
• Deutsches Krebsforschungszentrum Heidelberg
• European Molecular Biology Laboratory, Heidelberg
• Harvard Medical Web
• Harvard Stem Cell Institut
• Max-Planck-Institut für medizinische Forschung, Heidelberg
• Medizinische Fakultät der Ruprecht-Karls-Universität Heidelberg
• Stem Cell Information: The official National Institutes of Health resource for stem cell research
• The Brigham and Women's Hospital Inc., Boston, MA, USA
• The Stem Cell Program at Children´s Hospital Boston

NEWS

TICEBA receives SME eligibility of EMA. continue »
TICEBA now on facebook. continue »
next event:
29. - 31. May 2012, ECOPRAM - European Congress on Preventive, Regenerative and Anti-Aging Medicine, Istanbul (Turkey). Topic: "Autologous pluripotent mesenchymal stem cells from the skin". Booth: 12. continue »

NEWSLETTER

INFORMATIONS

Request any information from us now.

COUNSELLING

"We are glad to counsel you in person", Dr. Christoph Ganss:
+49 (0)6221.718 33 0
Legal notice | Disclaimer | Login
Copyright © 2012 - TICEBA GmbH